Aerosol formulation for pulmonary administration or diisobutyryl apomorphine, leuprolide acetate or analogues to produce a systemic effect

PK139953AUndetermined Publication Date: 2009-01-30CHIESI FARMACEUTICI SPA
0 Cites 0 Cited by

Patent Information

Application Number
PK200300157
Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
Publication Date
2009-01-30
Patent Text Reader

Abstract

The invention discloses an aerosol pharmaceutical composition comprising a medicament in solution in a mixture of a hydrofluoroalkane propellant and one or more co-solvents wherein the aerosol liquid droplets delivered on actuation of the inhaler have a particle size comprised between 0.5 um and 2.5 µm, with a mass median aerodynamic diameter of about 1-2 µm and wherein the fine particle fraction is at least 30%.
Need to check novelty before this filing date? Find Prior Art